|
시장보고서
상품코드
1843352
북미의 두개 임플란트 시장 보고서 : 시장 범위, 부문, 동향, 경쟁 분석(2021-2031년)North America Cranial Implants Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
||||||
북미의 두개 임플란트 시장은 2023년부터 2031년까지 연평균 복합 성장률(CAGR) 7.1%를 반영하여 2023년 6억 7,428만 달러에서 2031년에는 약 11억 6,677만 달러에 이르고, 크게 성장할 것으로 예측됩니다.
주요 요약 및 시장 분석
북미의 두개 임플란트 시장은 미국, 캐나다, 멕시코의 세 가지 주요 지역으로 나뉩니다. 외상성 뇌손상(TBI)의 높은 발생률, 인구 고령화, 의료 기술의 발전 등 여러 가지 요인이 이 시장의 성장을 가속하고 있습니다. 사고, 스포츠 관련 부상, 신경 장애 발생률 증가는 두개 임플란트에 대한 수요를 촉진하고 있습니다. 폴리에테르에테르케톤(PEEK) 및 티타늄과 같은 생체 적합성 재료의 혁신은 개인 맞춤형 솔루션을 위한 3D 프린팅의 사용과 함께 수술 결과를 개선하고 있습니다. 이 분야의 기업들은 두개 임플란트 수술을 보다 효과적이고 쉽게 이용할 수 있도록 기술 혁신에 집중하고 있습니다.
시장 세분화 분석
북미의 두개 임플란트 시장은 유형, 재료, 용도 등 다양한 부문으로 분석할 수 있습니다.
- 유형별: 시장은 정수리 임플란트, 전두부 임플란트, 후두부 임플란트, 측두부 임플란트, 측두부 임플란트, 나비형 뼈 임플란트로 분류됩니다. 2023년에는 정수리 임플란트가 가장 큰 시장 점유율을 차지했습니다.
- 재질별: 폴리메틸메타크릴레이트, 폴리에테르에테르케톤, 티타늄, 기타 등이 있습니다. 2023년 시장 점유율 1위는 폴리에테르 에테르 케톤이 차지했습니다.
- 최종 사용자별로는 병원, 외상센터, 기타가 포함되며, 2023년 점유율은 병원이 가장 큰 비중을 차지했습니다.
시장 전망
외상성 뇌손상은 공중보건의 큰 문제이며, 기계적인 외력에 의해 정상적인 뇌 기능이 손상됩니다. TBI의 일반적인 원인으로는 낙상, 자동차 사고, 스포츠 외상 등이 있으며, 주로 젊은 층과 노년층에서 많이 발생합니다. TBI는 경미한 뇌진탕부터 장기적인 인지장애, 신체적 장애, 정신적 장애로 이어지는 심각한 부상까지 다양합니다. 2022년 랜싯 신경학 위원회가 발표한 보고서에 따르면, TBI는 부상과 관련된 사망 및 장애의 주요 원인 중 하나이며, 전 세계적으로 5,500만 명이 영향을 받아 연간 4,000억 달러 이상의 비용이 발생한다고 합니다. 캐나다에서는 Waterloo-Wellington 뇌손상 협회의 보고에 따르면 매년 10만 명 중 500명이 TBI를 앓고 있으며, 연간 6,000명 이상의 환자가 TBI로 인해 후유장애를 앓고 있다고 합니다. 효과적인 치료법, 특히 두개 임플란트에 대한 수요 증가는 TBI 발생률 증가로 인해 발생했습니다. 이 임플란트는 심각한 두부 외상을 치료하고, 뇌를 추가 손상으로부터 보호하며, 두개골의 보호 기능을 회복하는 데 필수적입니다. TBI 사례가 계속 증가함에 따라 두개 임플란트에 대한 수요는 향후 몇 년 동안 크게 증가할 것으로 예측됩니다.
국가별 인사이트
북미의 두개 임플란트 시장은 주로 미국, 캐나다, 멕시코로 구성되어 있으며, 2023년에는 미국이 가장 큰 시장 점유율을 차지했습니다. 이 지역의 성장은 TBI의 높은 유병률, 고령화, 첨단 의료기술의 가용성에 기인합니다. 사고, 스포츠 외상, 신경 질환 증가는 두개 임플란트에 대한 수요를 더욱 촉진하고 있습니다. 생체 적합성 재료와 3D 프린팅 기술의 혁신으로 수술 결과가 향상되고, 시술이 더 효과적이고 쉽게 이용할 수 있게 되었습니다.
기업 소개
북미의 두개 임플란트 시장의 주요 기업으로는 Stryker Corp,Zimmer Biomet Holdings Inc,Integra LifeSciences Holdings Corp,OsteoMed SA,Anatomics Pty Ltd,Matrix Surgical Holdings LLC, Calavera Surgical, Medtronic Plc, Xilloc Medical BV, Johnson &Johnson, evonos GmbH &Co.KG, B Braun SE, UAB Ortho Baltic, 3D Systems Corp. GPC Medical Ltd, Bioplate Inc, EUROS SAS, Biocomposites Ltd, Medprin Biotech GmbH, Kelyniam Global Inc, MedCAD, KLS Martin Group, Longeviti Neuro Solutions LLC 등이 있습니다. 이들 기업은 제품 라인업을 강화하고 시장 점유율을 확대하기 위해 사업 확장, 제품 혁신, M&A 등 다양한 전략을 채택하고 있습니다.
목차
제1장 서론
제2장 주요 요약
- 주요 인사이트
제3장 조사 방법
- 2차 조사
- 1차 조사
- 가설 책정
- 거시경제 요인 분석
- 기초 수치 개발
- 데이터 삼각측량
- 국가 레벨 데이터
제4장 북미의 두개 임플란트 시장 구도
- PEST 분석
북미의 두개 임플란트 시장 : 주요 시장 역학
- 북미의 두개 임플란트 시장 : 주요 시장 역학
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
- 향후 동향
- 성장 촉진요인과 억제요인의 영향
제5장 북미의 두개 임플란트 시장 분석
- 북미의 두개 임플란트 시장 매출(2021년-2031년)
- 북미의 두개 임플란트 시장 예측 분석
제6장 북미의 두개 임플란트 시장 분석 : 유형별
- 두정부
- 전두부
- 후두부
- 측두
- 접형골
제7장 북미의 두개 임플란트 시장 분석 : 재료별
- 폴리 메타크릴산메틸
- 폴리에테르에테르케톤
- 티타늄
- 기타
제8장 북미의 두개 임플란트 시장 분석 : 최종사용자별
- 병원
- 외상센터
- 기타
제9장 북미의 두개 임플란트 시장 분석 : 국가별
- 북미
- 미국
- 캐나다
- 멕시코
제10장 업계 상황
- 인수합병(M&A)
- 제품 출시
- 사업 확대와 기타 전략적 개발
제11장 기업 개요
- Stryker Corp
- Zimmer Biomet Holdings Inc
- Integra LifeSciences Holdings Corp
- OsteoMed SA
- Anatomics Pty Ltd
- Matrix Surgical Holdings LLC
- Calavera Surgical
- Medtronic Plc
- Xilloc Medical BV
- Johnson & Johnson
- evonos GmbH & Co. KG
- B Braun SE
- UAB Ortho Baltic
- 3D Systems Corp
- GPC Medical Ltd
- Bioplate Inc
- EUROS SAS
- Biocomposites Ltd
- Medprin Biotech GmbH
- Kelyniam Global Inc
- MedCAD
- KLS Martin Group
- Longeviti Neuro Solutions LLC
제12장 부록
LSH 25.11.14The North America cranial implants market is projected to grow significantly, reaching approximately US$ 1,166.77 million by 2031, up from US$ 674.28 million in 2023, reflecting a compound annual growth rate (CAGR) of 7.1% from 2023 to 2031.
Executive Summary and Market Analysis
The cranial implants market in North America is divided into three main regions: the United States, Canada, and Mexico. Several factors are propelling the growth of this market, including a high incidence of traumatic brain injuries (TBI), an aging demographic, and advancements in medical technology. The increasing rates of accidents, sports-related injuries, and neurological disorders are driving the demand for cranial implants. Innovations in biocompatible materials, such as polyether ether ketone (PEEK) and titanium, along with the use of 3D printing for personalized solutions, are enhancing surgical outcomes. Companies in the sector are also focusing on innovation to make cranial implant procedures more effective and accessible.
Market Segmentation Analysis
The North America cranial implants market can be analyzed through various segments, including type, material, and application.
- By Type: The market is categorized into parietal, frontal, occipital, temporal, and sphenoid implants. In 2023, parietal implants accounted for the largest market share.
- By Material: The segmentation by material includes polymethyl methacrylate, polyether ether ketone, titanium, and others. Polyether ether ketone was the leading material in market share in 2023.
- By End User: The end-user segmentation includes hospitals, trauma centers, and others, with hospitals holding the largest share in 2023.
Market Outlook
Traumatic brain injuries are a major public health issue, disrupting normal brain function due to external mechanical forces. Common causes of TBIs include falls, motor vehicle accidents, and sports injuries, predominantly affecting younger and older adults. TBIs can range from mild concussions to severe injuries that lead to long-term cognitive, physical, and emotional disabilities. A report from The Lancet Neurology Commissions in 2022 highlighted that TBIs are among the leading causes of injury-related death and disability, impacting 55 million individuals globally and costing over US$ 400 billion annually. In Canada, the Brain Injury Association of Waterloo-Wellington reports that TBIs occur in 500 out of 100,000 people each year, with over 6,000 patients becoming permanently disabled due to TBIs annually. The rising demand for effective treatment options, particularly cranial implants, is driven by the increasing incidence of TBIs. These implants are essential for treating severe head injuries, protecting the brain from further damage, and restoring the skull's protective function. As TBI cases continue to rise, the demand for cranial implants is expected to increase significantly in the coming years.
Country Insights
The North America cranial implants market is primarily composed of the US, Canada, and Mexico, with the US holding the largest market share in 2023. The growth in this region is attributed to the high prevalence of TBIs, an aging population, and the availability of advanced medical technologies. The increasing number of accidents, sports injuries, and neurological conditions further fuels the demand for cranial implants. Innovations in biocompatible materials and 3D printing technology are improving surgical outcomes and making procedures more effective and accessible.
Company Profiles
Key players in the North America cranial implants market include Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, Calavera Surgical, Medtronic Plc, Xilloc Medical BV, Johnson & Johnson, evonos GmbH & Co. KG, B Braun SE, UAB Ortho Baltic, 3D Systems Corp, GPC Medical Ltd, Bioplate Inc, EUROS SAS, Biocomposites Ltd, Medprin Biotech GmbH, Kelyniam Global Inc, MedCAD, KLS Martin Group, and Longeviti Neuro Solutions LLC, among others. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their product offerings and increase market share.
Table Of Contents
1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Cranial Implants Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
North America Cranial Implants Market - Key Market Dynamics
- 4.3 North America Cranial Implants Market - Key Market Dynamics
- 4.4 Market Drivers
- 4.4.1 Increase in the Prevalence of Traumatic Brain Injuries
- 4.4.2 Surge in Elderly Populations
- 4.5 Market Restraints
- 4.5.1 Risk of Implant Failure
- 4.6 Market Opportunities
- 4.6.1 Advancements in 3D Printing with Incorporation of Original Multilayer Technology
- 4.7 Future Trends
- 4.7.1 Customized Implants
- 4.8 Impact of Drivers and Restraints:
5. North America Cranial Implants Market - Analysis
- 5.1 North America Cranial Implants Market Revenue (US$ Million), 2021-2031
- 5.2 North America Cranial Implants Market Forecast Analysis
6. North America Cranial Implants Market Analysis - by Type
- 6.1 Parietal
- 6.1.1 Overview
- 6.1.2 Parietal: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 6.2 Frontal
- 6.2.1 Overview
- 6.2.2 Frontal: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 6.3 Occipital
- 6.3.1 Overview
- 6.3.2 Occipital: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 6.4 Temporal
- 6.4.1 Overview
- 6.4.2 Temporal: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 6.5 Sphenoid
- 6.5.1 Overview
- 6.5.2 Sphenoid: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7. North America Cranial Implants Market Analysis - by Material
- 7.1 Polymethyl Methacrylate
- 7.1.1 Overview
- 7.1.2 Polymethyl Methacrylate: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.2 Polyether Ether Ketone
- 7.2.1 Overview
- 7.2.2 Polyether Ether Ketone: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.3 Titanium
- 7.3.1 Overview
- 7.3.2 Titanium: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Cranial Implants Market Analysis - by End User
- 8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 8.2 Trauma Centers
- 8.2.1 Overview
- 8.2.2 Trauma Centers: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Cranial Implants Market - Country Analysis
- 9.1 North America
- 9.1.1 North America Cranial Implants Market - Revenue and Forecast Analysis - by Country
- 9.1.1.1 North America Cranial Implants Market - Revenue and Forecast Analysis - by Country
- 9.1.1.2 United States: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 9.1.1.2.1 United States: North America Cranial Implants Market Share - by Type
- 9.1.1.2.2 United States: North America Cranial Implants Market Share - by Material
- 9.1.1.2.3 United States: North America Cranial Implants Market Share - by End User
- 9.1.1.3 Canada: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 9.1.1.3.1 Canada: North America Cranial Implants Market Share - by Type
- 9.1.1.3.2 Canada: North America Cranial Implants Market Share - by Material
- 9.1.1.3.3 Canada: North America Cranial Implants Market Share - by End User
- 9.1.1.4 Mexico: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 9.1.1.4.1 Mexico: North America Cranial Implants Market Share - by Type
- 9.1.1.4.2 Mexico: North America Cranial Implants Market Share - by Material
- 9.1.1.4.3 Mexico: North America Cranial Implants Market Share - by End User
- 9.1.1 North America Cranial Implants Market - Revenue and Forecast Analysis - by Country
10. Industry Landscape
- 10.1 Overview
- 10.2 Mergers and Acquisitions
- 10.3 Product Launch
- 10.4 Expansions and Other Strategic Developments
11. Company Profiles
- 11.1 Stryker Corp
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 Zimmer Biomet Holdings Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 Integra LifeSciences Holdings Corp
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 OsteoMed SA
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 Anatomics Pty Ltd
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Matrix Surgical Holdings LLC
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 Calavera Surgical
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
- 11.8 Medtronic Plc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
- 11.9 Xilloc Medical BV
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
- 11.10 Johnson & Johnson
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
- 11.11 evonos GmbH & Co. KG
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
- 11.12 B Braun SE
- 11.12.1 Key Facts
- 11.12.2 Business Description
- 11.12.3 Products and Services
- 11.12.4 Financial Overview
- 11.12.5 SWOT Analysis
- 11.12.6 Key Developments
- 11.13 UAB Ortho Baltic
- 11.13.1 Key Facts
- 11.13.2 Business Description
- 11.13.3 Products and Services
- 11.13.4 Financial Overview
- 11.13.5 SWOT Analysis
- 11.13.6 Key Developments
- 11.14 3D Systems Corp
- 11.14.1 Key Facts
- 11.14.2 Business Description
- 11.14.3 Products and Services
- 11.14.4 Financial Overview
- 11.14.5 SWOT Analysis
- 11.14.6 Key Developments
- 11.15 GPC Medical Ltd
- 11.15.1 Key Facts
- 11.15.2 Business Description
- 11.15.3 Products and Services
- 11.15.4 Financial Overview
- 11.15.5 SWOT Analysis
- 11.15.6 Key Developments
- 11.16 Bioplate Inc
- 11.16.1 Key Facts
- 11.16.2 Business Description
- 11.16.3 Products and Services
- 11.16.4 Financial Overview
- 11.16.5 SWOT Analysis
- 11.16.6 Key Developments
- 11.17 EUROS SAS
- 11.17.1 Key Facts
- 11.17.2 Business Description
- 11.17.3 Products and Services
- 11.17.4 Financial Overview
- 11.17.5 SWOT Analysis
- 11.17.6 Key Developments
- 11.18 Biocomposites Ltd
- 11.18.1 Key Facts
- 11.18.2 Business Description
- 11.18.3 Products and Services
- 11.18.4 Financial Overview
- 11.18.5 SWOT Analysis
- 11.18.6 Key Developments
- 11.19 Medprin Biotech GmbH
- 11.19.1 Key Facts
- 11.19.2 Business Description
- 11.19.3 Products and Services
- 11.19.4 Financial Overview
- 11.19.5 SWOT Analysis
- 11.19.6 Key Developments
- 11.20 Kelyniam Global Inc
- 11.20.1 Key Facts
- 11.20.2 Business Description
- 11.20.3 Products and Services
- 11.20.4 Financial Overview
- 11.20.5 SWOT Analysis
- 11.20.6 Key Developments
- 11.21 MedCAD
- 11.21.1 Key Facts
- 11.21.2 Business Description
- 11.21.3 Products and Services
- 11.21.4 Financial Overview
- 11.21.5 SWOT Analysis
- 11.21.6 Key Developments
- 11.22 KLS Martin Group
- 11.22.1 Key Facts
- 11.22.2 Business Description
- 11.22.3 Products and Services
- 11.22.4 Financial Overview
- 11.22.5 SWOT Analysis
- 11.22.6 Key Developments
- 11.23 Longeviti Neuro Solutions LLC
- 11.23.1 Key Facts
- 11.23.2 Business Description
- 11.23.3 Products and Services
- 11.23.4 Financial Overview
- 11.23.5 SWOT Analysis
- 11.23.6 Key Developments
12. Appendix
- 12.1 About Us
- 12.2 List of Abbreviations
